NVLN

Novelion Therapeutics Inc. Common Shares
NVLN

Overview Fund Activity
Delisted

NVLN was delisted on the 8th of October, 2019.

Back to rankings

35 hedge funds and large institutions have $5.35M invested in Novelion Therapeutics Inc. Common Shares in 2019 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
35
Holders Change
–
Holders Change %
0%
% of All Funds
0.76%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
7
Reduced
9
Closed
5
Calls
$46K
Puts
$85K
Net Calls
-$39K
Net Calls Change
-$105K

Top Buyers

1
SCM
Stonepine Capital Management
Oregon
+$383K
2
EIG
EdgePoint Investment Group
Ontario, Canada
+$320K
3
Goldman Sachs
Goldman Sachs
New York
+$202K
4
Group One Trading
Group One Trading
Illinois
+$37.9K
5
Citadel Advisors
Citadel Advisors
Florida
+$24.4K

Top Sellers

1
BC
Broadfin Capital
New York
-$897K
2
JAM
JW Asset Management
Florida
-$389K
3
AG
Artal Group
Luxembourg
-$315K
4
Millennium Management
Millennium Management
New York
-$29.5K
5
BlackRock
BlackRock
New York
-$23K
Name Holding Trade Value Shares
Change 		Shares
Change %
JAM
26
JW Asset Management
Florida
– -$389K -315,979 Closed
AG
27
Artal Group
Luxembourg
– -$315K -256,400 Closed
CCM
28
Context Capital Management
California
– -$52 -42,534 Closed
TRCT
29
Tower Research Capital (TRC)
New York
– -$1K -500 Closed
1
2